Literature DB >> 24463300

Modern management of Merkel cell carcinoma.

Gerhard F Huber1.   

Abstract

PURPOSE OF REVIEW: Merkel cell carcinoma (MCC) is a rare, aggressive malignancy. Worldwide incidence is increasing and roughly 50% of patients present with a primary lesion in the head and neck. This article discusses recent advances and treatment recommendations. RECENT
FINDINGS: Recent research has focused on the carcinogenesis of MCC, in particular the role of Merkel cell polyoma virus (MCPyV) and its surrogate marker large T-antigen. Together with cytokeratin 20 (CK20), other biomarkers like human insulin gene enhancer-binding protein islet-1 (ISL1) and transcription factor OCT4 may provide improved methods for diagnosis and ultimately, therapy.
SUMMARY: This review summarizes recent findings on MCC pathogenesis with a special emphasis on the impact of MCPyV. It further presents an overview of clinical aspects, and discusses treatment standards and emerging perspectives.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24463300     DOI: 10.1097/MOO.0000000000000029

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  3 in total

Review 1.  Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options.

Authors:  Alok T Saini; Brett A Miles
Journal:  Onco Targets Ther       Date:  2015-08-19       Impact factor: 4.147

2.  Merkel Cell Carcinoma: When Does Size Matter for Radiotherapy?

Authors:  Farshad Kasraei; Michelle Roach; Mark T Lee
Journal:  Cureus       Date:  2015-12-31

Review 3.  Burden of Disease, Early Diagnosis, and Treatment of Merkel Cell Carcinoma in Latin America.

Authors:  Rafael A Schmerling; Jose G Casas; Gabriela Cinat; Fabio Ernesto Grosso Ospina; Luiza E B P Kassuga; Jorge Luis Martinez Tlahuel; Luis Daniel Mazzuoccolo
Journal:  J Glob Oncol       Date:  2018-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.